Halozyme Therapeutics Q2 2023 Earnings Preview

• Halozyme Therapeutics (NASDAQ:HALO) is scheduled to announce Q2 earnings results on Tuesday, August 8th, after market close.
• The consensus EPS Estimate is $0.64 (+20.8% Y/Y) and the consensus Revenue Estimate is $199.95M (+31.2% Y/Y).
• Over the last 2 years, HALO has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
• Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 2 upward revisions and 2 downward.